These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28212578)

  • 1. Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy.
    Aleksova A; Beltrami AP; Carriere C; Barbati G; Lesizza P; Perrieri-Montanino M; Isola M; Gentile P; Salvioni E; Not T; Agostoni P; Sinagra G
    Oncotarget; 2017 Apr; 8(15):25131-25140. PubMed ID: 28212578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy.
    Luo B; Wang F; Li B; Dong Z; Liu X; Zhang C; An F
    Clin Chem Lab Med; 2013 Jul; 51(7):1521-8. PubMed ID: 23382313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The variable natural history of idiopathic dilated cardiomyopathy.
    Parakh K; Kittleson MM; Heidecker B; Wittstein IS; Judge DP; Champion HC; Barouch LA; Baughman KL; Russell SD; Kasper EK; Sitammagari KK; Hare JM
    Isr Med Assoc J; 2012 Nov; 14(11):666-71. PubMed ID: 23240370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.
    Limongelli G; Pacileo G; Ancona R; Eusebio G; D'Andrea A; Romano M; Di Salvo G; Rea A; Calabró P; Romano G; Maiello C; Calabró R
    Am J Cardiol; 2010 Mar; 105(5):716-20. PubMed ID: 20185022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy.
    Grimm W; Schmidt G; Maisch B; Sharkova J; Müller HH; Christ M
    J Cardiovasc Electrophysiol; 2003 Aug; 14(8):819-24. PubMed ID: 12890042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications.
    Pinamonti B; Perkan A; Di Lenarda A; Gregori D; Sinagra G
    Eur J Heart Fail; 2002 Jan; 4(1):49-61. PubMed ID: 11812665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.
    Rusconi P; Wilkinson JD; Sleeper LA; Lu M; Cox GF; Towbin JA; Colan SD; Webber SA; Canter CE; Ware SM; Hsu DT; Chung WK; Jefferies JL; Cordero C; Lipshultz SE;
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.
    Prabhu S; Ling LH; Ullah W; Hunter RJ; Schilling RJ; McLellan AJ; Earley MJ; Sporton SC; Voskoboinik A; Blusztein D; Mariani JA; Lee G; Taylor AJ; Kalman JM; Kistler PM
    J Cardiovasc Electrophysiol; 2016 Mar; 27(3):281-9. PubMed ID: 26707369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients.
    Wojciechowska C; Romuk E; Nowalany-Kozielska E; Jacheć W
    Hellenic J Cardiol; 2017; 58(5):350-359. PubMed ID: 28363768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K; Sasaki T; Hanatani A; Kim J; Hashimura K; Ishida Y; Ohkaru Y; Asayama K; Tanaka T; Ogai A; Nakatani T; Kitamura S; Kangawa K; Miyatake K; Kitakaze M
    Heart; 2006 May; 92(5):615-8. PubMed ID: 16387818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M; Merlo M; Pivetta A; Barbati G; Lutman C; Gregori D; Serdoz LV; Bardari S; Magnani S; Di Lenarda A; Proclemer A; Sinagra G
    Am J Cardiol; 2012 Mar; 109(5):729-35. PubMed ID: 22176998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy.
    Bocchi EA; Bellotti G; Moreira LF; Bacal F; de Moraes AV; Fiorelli A; Mansur A; Stolf N; Jatene A; Pileggi F
    J Heart Lung Transplant; 1996 Jul; 15(7):736-45. PubMed ID: 8820791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.